Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) Operating Income Growth (5y) (2014 - 2026)

Analysis

Haemonetics (HAE) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 110.51%
Mar 28, 2026 -1.69%
Dec 27, 2025 10.76%
Sep 27, 2025 -0.10%
Jun 28, 2025 35.68%
Mar 29, 2025 22.36%
Dec 28, 2024 7.61%
Sep 28, 2024 0.78%
Jun 29, 2024 37.91%
Mar 30, 2024 4.65%
Dec 30, 2023 10.18%
Sep 30, 2023 6.25%
Jul 1, 2023 58.92%
Apr 1, 2023 19.82%
Dec 31, 2022 111.90%
Oct 1, 2022 14.01%
Jul 2, 2022 13.12%
Apr 2, 2022 18.47%
Jan 1, 2022 10.94%
Oct 2, 2021 -0.23%